| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $336,140 ) |
| | 2025 | 2025 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R21AG091047 | Mechanistic tRNA modification affects to aging | 000 | 1 | NIH | 11/14/2024 | $430,603 |
| | 2025 | 2022 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AI165521 | Novel antiviral mechanisms of the interferon system | 000 | 1 | NIH | 10/21/2024 | -$94,462 |
| | 2025 | 2021 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK114006 | The Melanocortinergic pathway inglomerular disease | 000 | 6 | NIH | 11/7/2024 | -$1 |
|
| Issue Date FY: 2024 ( Subtotal = $14,448,701 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AI153496 | Understanding the proviral role for TRAF6 interaction with the viral protease in flavivirus replication and pathogenesis | 000 | 5 | NIH | 4/18/2024 | $386,250 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK134053 | Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease | 000 | 2 | NIH | 1/31/2024 | $387,115 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01NS122534 | Pre and post-synaptic pathways underlying the stress response in the adrenal medulla | 000 | 9 | NIH | 2/19/2024 | $333,140 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 000 | 6 | NIH | 1/11/2024 | $318,077 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R03AG080418 | Cerebrovascular endothelial cilia in the pathogenesis and therapy of Alzheimer's disease | 000 | 2 | NIH | 1/23/2024 | $136,598 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R03AG080418 | Cerebrovascular endothelial cilia in the pathogenesis and therapy of Alzheimer's disease | 001 | 2 | NIH | 6/21/2024 | $15,177 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01NS112642 | Cofilin Signaling in Hemorrhagic Stroke | 001 | 5 | NIH | 8/2/2024 | -$11,620 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01NS112642 | Cofilin Signaling in Hemorrhagic Stroke | 001 | 5 | NIH | 8/2/2024 | $11,620 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01NS112642 | Cofilin Signaling in Hemorrhagic Stroke | 000 | 5 | NIH | 4/5/2024 | $364,090 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01NS112642 | Cofilin Signaling in Hemorrhagic Stroke | 000 | 5 | NIH | 4/5/2024 | $23,240 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | S10OD036266 | Acquisition of a FACSymphony S6 Sorter for the University of Toledo Flow Cytometry Core | 000 | 1 | NIH | 8/26/2024 | $350,000 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R21AI176323 | Structure and function of Borna disease virus polymerase | 000 | 2 | NIH | 7/22/2024 | $196,465 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | T32GM144873 | Training in Molecular and translational Cell Dynamics | 001 | 3 | NIH | 7/2/2024 | $19,997 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | T32GM144873 | Training in Molecular and translational Cell Dynamics | 000 | 3 | NIH | 4/17/2024 | $653,082 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | U01DA054330 | Cross platform analysis of drug targets and toxicity of bath salts | 001 | 3 | NIH | 6/7/2024 | $556,470 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | U01DA054330 | Cross platform analysis of drug targets and toxicity of bath salts | 002 | 3 | NIH | 6/28/2024 | $389,265 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R03CA286634 | TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer | 002 | 2 | NIH | 9/10/2024 | $49,202 |
| | 2024 | 2024 | University of Toledo | 3000 Arlington Ave | Toledo | OH | 43614-2598 | LUCAS | USA | T03OH008605 | NIOSH Training Project Grant (TPG): Industrial Hygiene - University of Toledo | 00 | 19 | CDC | 5/21/2024 | $86,963 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R00HL153896 | YAP1, neointima formation, and blood pressure regulation | 001 | 4 | NIH | 6/26/2024 | $24,899 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 Arlington Ave | Toledo | OH | 43614-2598 | LUCAS | USA | U7723072 | Area Health Education Centers Point of Service Maintenance and Enhancement | 00 | 14 | HRSA | 8/9/2024 | $1,446,948 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R00HL153896 | YAP1, neointima formation, and blood pressure regulation | 000 | 4 | NIH | 12/4/2023 | $224,101 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01HD104418 | Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism | 000 | 3 | NIH | 1/18/2024 | $479,823 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK133203 | Role of GSK3beta in diabetic kidney disease | 000 | 3 | NIH | 7/1/2024 | $326,304 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01HD104418 | Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism | 001 | 3 | NIH | 5/2/2024 | $47,982 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AA029674 | Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies | 000 | 3 | NIH | 5/30/2024 | $419,512 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R21DA055558 | Zebrafish Screens to Identify Agents which Reverse the Effects of Synthetic Opioids | 000 | 2 | NIH | 3/14/2024 | $154,500 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA258682 | Targeting eIF4A1 in drug-resistant breast cancer stem-like cells | 002 | 3 | NIH | 9/9/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA258682 | Targeting eIF4A1 in drug-resistant breast cancer stem-like cells | 000 | 3 | NIH | 7/22/2024 | $388,292 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA258682 | Targeting eIF4A1 in drug-resistant breast cancer stem-like cells | 001 | 3 | NIH | 8/9/2024 | $249,381 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AG071332 | PPARG regulates osteocyte bioenergetics and function during aging | 000 | 4 | NIH | 6/4/2024 | $682,204 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK124098 | Gut-brain axis in Parkinson's disease | 000 | 4 | NIH | 8/26/2024 | $1 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AG083628 | Investigation of active kinome networks in Alzheimer's dementia. | 000 | 1 | NIH | 9/10/2024 | $788,021 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA287731 | Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer | 000 | 1 | NIH | 9/13/2024 | $571,496 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01AI184880 | Determining role of 14-3-3zeta in IL-17A signaling | 001 | 1 | NIH | 9/3/2024 | $77,603 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R21CA277252 | Targeting FASN to eliminate metastatic breast cancer in the brain | 000 | 2 | NIH | 6/13/2024 | $205,853 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R21ES036352 | Developmental pyrethroid exposure in the Shank3 mutant prairie vole as a 2-hit model for neurodevelopmental disorder risk | 000 | 1 | NIH | 8/14/2024 | $421,047 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | F30AG079633 | AMPK localization, expression, and activity in Alzheimer's Disease | 000 | 3 | NIH | 8/9/2024 | $42,791 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | K01AA029763 | Targeting PI3K/BRD4 and Hedgehog Pathway in Alcohol Associated Liver Disease | 002 | 5 | NIH | 7/31/2024 | $105,638 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01CA276732 | Engineering Exosome for Pancreatic Cancer Targeting Therapies | 000 | 2 | NIH | 8/21/2024 | $487,361 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 Arlington Ave | Toledo | OH | 43614-2598 | LUCAS | USA | H1224838 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 00 | 12 | HRSA | 7/1/2024 | $507,781 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01DK134053 | Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease | 001 | 2 | NIH | 5/15/2024 | $25,807 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2598 | LUCAS | USA | R01HL171401 | Conjugated bile acids as nutritionally re-programmable antihypertensive metabolites | 000 | 1 | NIH | 7/16/2024 | $768,896 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 Arlington Ave | Toledo | OH | 43614-2598 | LUCAS | USA | H7600732 | Ryan White Part C Outpatient EIS Program | 02 | 23 | HRSA | 8/2/2024 | $10,407 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 Arlington Ave | Toledo | OH | 43614-2598 | LUCAS | USA | H7600732 | Ryan White Part C Outpatient EIS Program | 01 | 23 | HRSA | 5/24/2024 | $387,751 |
| | 2024 | 2024 | UNIVERSITY OF TOLEDO | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | H7600732 | Ryan White Part C Outpatient EIS Program | 00 | 23 | HRSA | 1/26/2024 | $129,249 |
|
